What does it mean to have functional high-risk multiple myeloma?
In this week’s #AskDrDurie, myeloma expert Dr. Brian G.M. Durie discusses what it means when a patient is functionally high risk and what new therapies may benefit these patients.
The BOTTOM LINE: Emerging immune therapies, such as CAR-T therapies or bispecific monoclonal antibodies, may benefit patients who are functionally high-risk.
_______________
Improving Lives | Finding the Cure
Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest organization focusing specifically on multiple myeloma. The IMF’s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of lives of myeloma patients while working toward prevention and a cure through our four founding principles: Research, Education, Support, and Advocacy.
Subscribe to our channel: https://www.youtube.com/c/IMFMyeloma
Visit our website at: https://www.myeloma.org
Find us online:
Facebook: @myeloma | https://facebook.com/myeloma
Twitter: @IMFMyeloma | https://twitter.com/IMFmyeloma
Instagram: @imfmyeloma | https://www.instagram.com/imfmyeloma
LinkedIn: https://www.linkedin.com/compa....ny/international-mye
Support the IMF | Donate Now! https://secure.myeloma.org/page/40697/donate/1
Category
Nonprofits & Activism
License
Standard YouTube License
In most cases, captions are autogenerated by YouTube.
-
Category
No comments found